The American Society of Human Genetics (ASHG) has officially unveiled the winners of its highly anticipated 2026 DNA Day Essay Contest. As the scientific community celebrates the profound impact of genomics on modern medicine, this year’s competition highlighted a new generation of scholars who are not only grasping the complexities of gene therapy but are also analyzing the ethical, societal, and medical implications of breakthroughs that were once relegated to the realm of science fiction.
The contest, an annual cornerstone of K-12 genetic education, challenges students worldwide to bridge the gap between abstract biological concepts and real-world medical applications. By analyzing recent advancements such as Casgevy and Roctavian, the 2026 participants demonstrated a level of intellectual rigor that underscores the growing importance of genetic literacy in the 21st century.
The 2026 Laureates: Global Excellence in Genetic Inquiry
This year’s competition drew submissions from a diverse array of international schools, reflecting the global nature of genetic research. The top three entries were selected after a grueling, multi-stage evaluation process.
1st Place: Carla Monté
Representing La Vall in Sabadell, Spain, 10th-grade student Carla Monté secured the top honor. Under the guidance of her teacher, Mrs. Margarita Sihuro, Monté produced an essay that judges described as both conceptually sophisticated and deeply empathetic. Her analysis of modern gene-editing therapies set a new standard for the competition, earning her the top spot in a field of exceptionally talented peers.
2nd Place: Shiree Lapin
The second-place award was presented to Shiree Lapin, an 11th-grade student at Acellus Academy in Kansas City, Missouri. Mentored by Ms. Sam Lapin, Shiree’s work provided a compelling exploration of the intersection between biotechnology and patient accessibility, showcasing a nuanced understanding of how genetic therapies transition from laboratory settings to clinical reality.
3rd Place: Dragoș-Andrei Drăghici
Rounding out the top three is Dragoș-Andrei Drăghici, a 10th-grade student at Colegiul Național "Octavian Goga" in Sibiu, Romania. Guided by his teacher, Ms. Codruța Dorina Burlea, Drăghici offered a rigorous, evidence-based argument regarding the long-term potential of emerging genetic treatments. His success highlights the strong emphasis on scientific education within the Romanian academic landscape.
A Chronology of the 2026 Contest Cycle
The road to selecting these winners was a lengthy, deliberate process designed to ensure that every student’s voice was heard and evaluated with the utmost objectivity.
- Phase I: The Call for Entries (Early 2026): The competition opened with a prompt focused on the rapid evolution of genetic therapies. Students were asked to select a specific treatment—such as the CRISPR-based Casgevy for sickle cell disease or the gene therapy Roctavian for hemophilia—and argue its significance in the current medical landscape.
- Phase II: The Judging Gauntlet: The ASHG employs a rigorous three-round judging process. Every essay submitted is read by at least three independent judges. As essays progress through the rounds, the scrutiny increases. The top-scoring essays often undergo review by a dozen or more experts in genetics and education, ensuring that the winners possess not just factual accuracy, but also the ability to synthesize complex arguments.
- Phase III: Verification and Final Selection (April 2026): Following the final round of scoring, the ASHG verification team cross-referenced the winning entries with current academic standards and confirmed the student standings.
- Phase IV: Announcement (DNA Day): The results were officially released on DNA Day, a date that commemorates the discovery of the double helix structure of DNA in 1953 and the completion of the Human Genome Project in 2003.
Supporting Data: The Standard of Excellence
What makes the ASHG DNA Day Essay Contest unique is its demand for substantive, well-reasoned, and evidence-based argumentation. Unlike general writing competitions, this contest requires students to act as quasi-scientists.
According to internal metrics from the ASHG, the 2026 cohort displayed a 15% increase in the usage of peer-reviewed literature citations compared to the 2024 cohort. The judges noted that the students’ ability to grapple with the complexities of "off-target effects" in gene editing and the "cost-benefit analysis" of high-priced genomic medicines was particularly impressive for high school students.
The evaluation criteria are split into three primary domains:
- Scientific Accuracy: Does the student demonstrate a mastery of the underlying mechanism of the therapy chosen?
- Critical Reflection: Does the student move beyond description to provide a thoughtful critique of the therapy’s impact on society, patient outcomes, or ethical standards?
- Communication Clarity: Is the argument structured in a way that is accessible yet academically rigorous?
Official Responses and Educational Philosophy
The ASHG’s leadership has consistently championed the essay contest as more than just an awards program. It is a pedagogical tool designed to cultivate the next generation of researchers, doctors, and informed citizens.
"The goal is not simply to reward the student who knows the most biology," stated an ASHG spokesperson. "It is to challenge students to examine, question, and reflect. When a 10th grader from Spain or a 11th grader from Missouri starts discussing the regulatory hurdles of gene therapy, we know that the next generation is prepared to lead the conversation on human genetics."
The contest organizers emphasize that the diversity of the winners—hailing from Spain, the United States, and Romania—is a testament to the universal language of science. By removing geographic barriers to participation, the ASHG ensures that the best minds from every continent have the opportunity to showcase their potential.
The Implications of Genetic Literacy
The focus of the 2026 essay contest on therapies like Casgevy and Roctavian is deeply symbolic of the current era of medicine. We are moving from a model of reactive medicine (treating symptoms) to a model of proactive, genetic-based intervention.
Why This Matters for the Future
- The Rise of Genomic Medicine: As CRISPR-Cas9 and other gene-editing tools become more refined, the public discourse must evolve. The students who participated in this contest are the future policy-makers, scientists, and ethicists who will decide how these tools are used.
- Democratizing Science: By asking students to write about complex treatments, the ASHG is encouraging them to demystify science for the broader public. The ability to explain a genetic therapy in a compelling essay is the first step toward effective science communication.
- Encouraging STEM Engagement: Programs like this serve as a vital bridge between the classroom and the laboratory. For many of the participants, this contest serves as a "first publication" or a validation of their passion for science, often acting as a catalyst for their future university studies in biotechnology, medicine, or molecular biology.
Conclusion: Looking Ahead
As the 2026 contest concludes, the ASHG is already looking toward the future. The winning essays serve as a repository of student-led thought on the most pressing issues in genetics. Those interested in reading the full submissions from Carla Monté, Shiree Lapin, and Dragoș-Andrei Drăghici can visit the official ASHG website.
The success of these students is a reminder that the mysteries of our genetic code, while daunting, are being unraveled by a generation that is eager, informed, and ready to face the challenges of the future. Happy DNA Day to all the participants, teachers, and families who contributed to making the 2026 cycle a resounding success. The future of genetics is in capable hands.
About the Author
